VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
UPLOAD

UPLOAD

Other
View HTML
PREC14A

Preliminary proxy statement containing contested solicitations

Proxy Filings
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DFAN14A

Additional proxy soliciting materials filed by non-management

Proxy Filings
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |